ORTHOPEDIATRICS CORP 8-K

What Happened

• On February 26, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter and year ended December 31, 2025. The company also provided management's projections for 2026 revenue, EBITDA and break-even cash flow. The press release, which includes unaudited condensed consolidated financial statements and additional financial data for the quarter and year ended December 31, 2025, was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: February 26, 2026 (Form 8-K Items 2.02 and 9.01).
• Period covered: quarter and fiscal year ended December 31, 2025.
• Management disclosed forward-looking targets for 2026: revenue, EBITDA and break-even cash flow (specific figures provided in the furnished press release).
• The press release includes unaudited condensed consolidated financial statements and other financial data (Exhibit 99.1).

Why It Matters

• Earnings and the accompanying financial statements give investors primary, timely information about OrthoPediatrics’ recent performance and financial condition for Q4 and full-year 2025.
• Management’s 2026 revenue, EBITDA and break-even cash flow projections provide guidance on expected growth and near-term path to profitability or cash flow improvement, which can affect valuation and trading decisions.
• Retail investors should review the furnished press release and financial statements (Exhibit 99.1) for the specific figures and metrics, and watch for subsequent SEC filings (e.g., Form 10-Q or Form 10-K) for audited results and additional context.